Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| BESSEMER GROUP INC | AFK VanEck ETF Trust | 13G | 8.69% | Dec 31, 2023 | 2y |
| TIAA-CREF Investment Management, LLC | ALT Altimmune, Inc. | 13G/A | 2.88% | Dec 31, 2023 | 2y |
| PURA VIDA INVESTMENTS, LLC | NSTG NanoString Technologies, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Kopernik Global Investors, LLC | NAK Northern Dynasty Minerals Ltd | 13G/A | 6.62% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | DHX Dhi Group, Inc. | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| Atlas Merchant Capital LLC | HCVI Hennessy Capital Investment Corp. VI Class A Common Stock | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| Madison Avenue Partners, LP | OVID Ovid Therapeutics Inc. | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| 683 Capital Management, LLC | PANA Panacea Acquisition Corp. II Class A Ordinary Shares | 13G/A | 0% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | APCA AP Acquisition Corp | 13G | 5.34% | Dec 31, 2023 | 2y |
| Redmile Group, LLC | REPL Replimune Group, Inc. | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | UNCY Unicycive Therapeutics, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | YYAI Airwa Inc. | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | GMFI Aetherium Acquisition Corp. Class A Common Stock | 13G | 5.65% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | EOCN EoCene Ltd. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | AENT Alliance Entertainment Holding Corp | 13G/A | 0% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | EWTX Edgewise Therapeutics, Inc. | 13G/A | 4% | Dec 31, 2023 | 2y |
| CVI Investments, Inc. | EBET EBET, INC. Common Stock | 13G/A | 0.4% | Dec 31, 2023 | 2y |
| Dan Oren | ROIV Roivant Sciences Ltd. | 13G/A | 12.78% | Dec 31, 2023 | 2y |
| Oaktree Capital Holdings, LLC | FEXD Fintech Ecosystem Development Corp. Class A Common Stock | 13G | 0% | Dec 31, 2023 | 2y |
| Fourthstone LLC | MRBK Meridian Corp | 13G | 9.27% | Dec 31, 2023 | 2y |
| Scooby Aggregator, LP | WOOF Petco Health & Wellness Company, Inc. | 13G/A | 68.4% | Dec 31, 2023 | 2y |
| TENOR CAPITAL MANAGEMENT Co., L.P. | ACAH Atlantic Coastal Acquisition Corp. Class A Common Stock | 13G/A | 6.6% | Dec 31, 2023 | 2y |
| RPD Fund Management LLC | GRPN Groupon, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | MRTX Mirati Therapeutics, Inc. Common Stock | 13G/A | 7% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | HSPOF Horizon Space Acquisition I Corp. | 13G | 6.56% | Dec 31, 2023 | 2y |
| JANUS HENDERSON GROUP PLC | LNTH Lantheus Holdings, Inc. | 13G | 5.8% | Dec 31, 2023 | 2y |
| Bell Edward Allen | OVBC Ohio Valley Banc Corp | 13G | 8.02% | Dec 31, 2023 | 2y |
| First Light Asset Management, LLC | PHLT Performant Healthcare, Inc. Common Stock | 13G/A | 13.43% | Dec 31, 2023 | 2y |
| ORBIMED ADVISORS LLC | VSTM Verastem, Inc. | 13G/A | 6.1% | Dec 31, 2023 | 2y |
| Galileo (PTC) Ltd | HOOD Robinhood Markets, Inc. | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | RYZB RayzeBio, Inc. Common Stock | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| Dragoneer Investment Group, LLC | GTM ZoomInfo Technologies Inc. | 13G | 5.7% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | ESAB ESAB Corp | 13G/A | 14% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | IOBTQ IO Biotech, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Travis Boersma | BROS Dutch Bros Inc. | 13G/A | 52.13% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | CCCC C4 Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| BAKER BROS. ADVISORS LP | TSVT 2seventy bio, Inc. Common Stock | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| RBC Global Asset Management Inc. | TXR Torex Resources Inc. | 13G/A | 4.33% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | MBIO Mustang Bio, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| COMPASS GROUP LLC | VSTA Vasta Platform Limited Class A Ordinary Shares | 13G/A | 21.8% | Dec 31, 2023 | 2y |
| Calamos Market Neutral Income Fund, a series of Calamos Investment Trust | HMA Heartland Media Acquisition Corp. | 13G | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | NTST NETSTREIT Corp. | 13G | 7.2% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | REPL Replimune Group, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Checkpoint Capital L.P. | KALA KALA BIO, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| SPROTT INC. | GATO Gatos Silver, Inc. | 13G | 5% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | FZT FAST Acquisition Corp. II | 13G/A | 0% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | ELDN Eledon Pharmaceuticals, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | SEE SEALED AIR CORP | 13G | 7.2% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | APLS Apellis Pharmaceuticals, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | ASND Ascendis Pharma A/S | 13G/A | 17.5% | Dec 31, 2023 | 2y |